Create Free Account

By creating account you will get access to hot stocks & personalised emails

Clover Corporation Ltd

Consumer Defensive AU CLV

0.51AUD
-0.01(1.92%)

Last update at 2024-05-20T01:24:00Z

Day Range

0.510.52
LowHigh

52 Week Range

0.461.30
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Income before tax 8.36M 9.84M 8.18M 17.66M 13.96M
Minority interest - - - - -
Net income 6.21M 7.13M 6.00M 12.49M 10.10M
Selling general administrative 5.51M 4.56M 3.79M 5.36M 5.32M
Selling and marketing expenses 5.69M 4.00M 3.13M 3.79M 3.60M
Gross profit 23.74M 21.53M 18.24M 29.71M 23.92M
Reconciled depreciation 0.92M 0.71M 0.71M 0.68M 0.41M
Ebit 9.09M 10.29M 8.58M 18.24M 14.29M
Ebitda 10.01M 11.01M 9.28M 18.92M 14.70M
Depreciation and amortization 0.92M 0.71M 0.71M 0.68M 0.41M
Non operating income net other - - - - -
Operating income 9.09M 10.29M 8.58M 18.24M 14.29M
Other operating expenses 71.51M 60.26M 51.69M 70.60M 63.51M
Interest expense 0.73M 0.46M 0.40M 0.59M 0.33M
Tax provision 2.16M 2.71M 2.17M 5.17M 3.86M
Interest income 1.22M 1.11M 1.34M 0.63M 0.71M
Net interest income -0.73000M -0.45500M -0.40100M -0.58800M -0.31800M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.16M 2.71M 2.17M 5.17M 3.86M
Total revenue 79.88M 70.66M 60.51M 88.28M 76.68M
Total operating expenses 15.37M 11.13M 9.43M 12.03M 10.74M
Cost of revenue 56.14M 49.13M 42.27M 58.57M 52.76M
Total other income expense net -0.19300M -0.45500M -0.40100M -0.58800M -0.33000M
Discontinued operations - - - - -
Net income from continuing ops 6.21M 7.13M 6.00M 12.49M 10.10M
Net income applicable to common shares 6.21M 7.13M 6.00M 12.49M 10.10M
Preferred stock and other adjustments - - - - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Total assets 86.20M 90.60M 78.73M 81.49M 74.75M
Intangible assets - - - - 1.91M
Earning assets - - - - -
Other current assets 1.74M 1.22M 1.60M 1.12M 0.96M
Total liab 19.05M 27.56M 20.32M 23.92M 29.61M
Total stockholder equity 67.15M 63.04M 58.42M 57.57M 45.14M
Deferred long term liab - - - - -
Other current liab 2.20M 6.43M 1.18M 2.92M 8.12M
Common stock 36.27M 35.60M 35.60M 35.37M 32.92M
Capital stock 36.27M 35.60M 35.60M 35.37M 32.92M
Retained earnings 31.74M 28.45M 22.98M 21.96M 12.39M
Other liab 1.18M 0.02M 0.03M 0.08M 0.06M
Good will 1.91M 1.91M 1.91M 1.91M 1.91M
Other assets 1.29M 0.84M 0.91M 1.08M 1.25M
Cash 9.44M 10.11M 9.09M 9.24M 8.27M
Cash and equivalents - - - - -
Total current liabilities 8.29M 17.25M 7.84M 10.94M 17.56M
Current deferred revenue - - - - -
Net debt 2.27M 1.97M 5.09M 5.38M 5.19M
Short term debt 2.13M 1.78M 1.74M 1.71M 1.47M
Short long term debt 1.74M 1.67M 1.62M 1.62M 1.47M
Short long term debt total 11.71M 12.08M 14.19M 14.62M 13.46M
Other stockholder equity -0.18900M -1.01100M -0.16600M 0.24M -0.16600M
Property plant equipment 11.34M 9.18M 8.10M 5.85M 5.78M
Total current assets 60.01M 66.86M 54.74M 59.07M 55.36M
Long term investments 11.66M 11.82M 13.07M 13.58M 10.46M
Net tangible assets 65.24M 61.13M 56.51M 55.66M 43.23M
Short term investments - - - - -
Net receivables 11.95M 19.56M 13.27M 16.78M 18.45M
Long term debt 7.69M 9.24M 11.45M 12.90M 11.99M
Inventory 36.88M 35.97M 30.78M 31.93M 27.68M
Accounts payable 3.96M 9.04M 4.92M 6.30M 7.97M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.85500M -1.01100M -0.16600M 0.24M -0.16600M
Additional paid in capital - - - - -
Common stock total equity - - - 35.37M 32.92M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 19.39M
Deferred long term asset charges - - - - -
Non current assets total 26.20M 23.74M 24.00M 22.41M 19.39M
Capital lease obligations 2.28M 1.17M 1.11M 0.10M -
Long term debt total 9.58M 10.30M 12.45M 12.90M 11.99M
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Investments -2.52900M -1.59800M -1.83100M -3.46100M -10.48100M
Change to liabilities -8.69000M 0.07M -2.55100M -2.07300M 3.94M
Total cashflows from investing activities -2.52900M -1.59800M -1.83100M -4.01700M -10.58900M
Net borrowings -1.96400M -2.30000M -1.55800M 1.24M 9.27M
Total cash from financing activities -4.88100M -3.96400M -6.54700M -1.67400M 6.17M
Change to operating activities 1.48M 1.97M 0.07M -0.11700M -0.25700M
Net income 6.21M 7.13M 6.00M 12.49M 10.10M
Change in cash -0.67400M 1.02M -0.15000M 0.97M 0.38M
Begin period cash flow 10.11M 9.09M 9.24M 8.27M 7.89M
End period cash flow 9.44M 10.11M 9.09M 9.24M 8.27M
Total cash from operating activities 6.74M 7.84M 8.23M 6.66M 4.79M
Issuance of capital stock - - - - -
Depreciation 0.81M 0.71M 0.71M 0.68M 0.41M
Other cashflows from investing activities -0.89000M -0.89000M -0.89000M -3.46100M -10.48100M
Dividends paid -2.91700M -1.66400M -4.98900M -2.91000M 3.10M
Change to inventory -0.91200M -5.18800M 1.16M -4.25200M -7.91300M
Change to account receivables 7.61M -6.29700M 3.52M 1.67M -3.18900M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.22900M -0.13400M -0.11500M 2.80M 14.33M
Change to netincome 0.19M 0.41M 0.34M 0.66M 0.66M
Capital expenditures 1.64M 1.60M 1.83M 0.56M 0.11M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.73000M -0.45600M -0.40100M -0.58800M -0.31800M
Stock based compensation - - - - -
Other non cash items - -7.84500M -6.71100M -13.16600M -10.51000M
Free cash flow -1.63900M 6.25M -1.83100M -0.55600M -0.10800M

Fundamentals

  • Previous Close 0.52
  • Market Cap86.84M
  • Volume13420
  • P/E Ratio52.00
  • Dividend Yield2.88%
  • EBITDA4.28M
  • Revenue TTM62.77M
  • Revenue Per Share TTM0.37
  • Gross Profit TTM 23.74M
  • Diluted EPS TTM0.01

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CLV
Clover Corporation Ltd		 -0.01 1.92% 0.51 52.00 26.18 1.36 1.30 1.48 20.84
A2M
A2 Milk Company Ltd		 -0.175 2.60% 6.57 32.10 22.12 2.59 4.00 2.24 14.49
BGA
Bega Cheese Ltd		 0.01 0.35% 4.29 - 25.58 0.37 1.24 0.50 -14.1507
CBO
Cobram Estate Olives Ltd		 -0.015 0.83% 1.78 89.00 - 3.68 3.00 4.74 20.80
RIC
Ridley Corporation Ltd		 0.005 0.24% 2.10 16.15 15.50 0.61 2.41 0.66 9.13

Reports Covered

Stock Research & News

View All

Profile

Clover Corporation Limited engages in the business of manufacturing, refining, and sale of tuna oil and encapsulated products in Australia, New Zealand, Asia, Europe, and the Americas. The company offers docosahexaenoic acid (DHA) tuna oils under the Nu-Mega HiDHA brand name for use in infant formula and pharmaceutical products; and cold pressed and refined tuna oils under the Ocean Gold brand name. It also provides DHA powders, including Nu-Mega Driphorm powders, used in a range of infant formula, follow-on formula, growing up milks, and food applications; Nu-Mega Driphorm HA for non-dairy applications; and microencapsulation. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.

Clover Corporation Ltd

39 Pinnacle Road, Altona North, VIC, Australia, 3025

Key Executives

Name Title Year Born
Mr. Peter J. Davey GAICD, gradDip Bus., MBA CEO, MD & Exec. Director NA
Mr. Andrew G. M. Allibon C.A. CFO & Company Sec. NA
Mr. David Pierotti Operations Mang. NA
Mr. Timothy Murphy Human Resource & Payroll Mang. NA
S. Poothong Chief Commercial Officer NA
Mr. Peter J. Davey GAICD, gradDip Bus., MBA CEO, MD & Executive Director NA
Mr. Andrew G. M. Allibon C.A. CFO & Company Secretary NA
Mr. David Pierotti Director of Operations NA
Mr. Bassam Hallak Director of Sales & Marketing NA
Ms. Anne Roach General Manager of People & Culture NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.